Palang Chotsiri
Senior Scientist, Clinical Pharmacology
Currently a senior scientist at MORU's Department of Clinical Pharmacology, Palang is a trained physicist. He uses pharmacokinetic and pharmacodynamic modelling and simulation as his main research tools. The use of mathematical and statistical modelling to solve biological problems fascinates Palang, since he can use mathematical equations to translate data into meaningful and impactful outcomes. Palang holds a PhD in Tropical Medicine, focusing on optimising anti-malarial drug regimens in several populations.
Palang's research aims to characterise the pharmacokinetic and pharmacodynamic properties of anti-infectious drugs in vulnerable populations, with the goal of optimising treatment and chemoprevention in these populations while also providing evidence to inform global treatment policies. Additionally, he intends to advance pharmacometric modelling methodologies to facilitate research in this field and communicate with a wider scientific community.
Recent publications
-
Cardiovascular concentration–effect relationships of amodiaquine and its metabolite desethylamodiaquine: Clinical and preclinical studies
Journal article
Chan XHS. et al, (2023), British Journal of Clinical Pharmacology, 89, 1176 - 1186
-
Transcriptome profiling of male and female Ascaris lumbricoides reproductive tissues.
Journal article
Phuphisut O. et al, (2022), Parasites & vectors, 15
-
Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers
Journal article
Chotsiri P. et al, (2022), Clinical Pharmacology & Therapeutics, 112, 824 - 835
-
A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics.
Journal article
Wattanakul T. et al, (2022), Expert Rev Clin Pharmacol
-
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
Journal article
Assmus F. et al, (2022), Microorganisms, 10, 1639 - 1639